Oncolytics Biotech Inc (ONCY)
1.08
+0.02
(+1.89%)
USD |
NASDAQ |
Apr 25, 16:00
1.08
0.00 (0.00%)
After-Hours: 20:00
Oncolytics Biotech Price to Book Value: 3.920 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 3.920 |
| April 24, 2024 | 3.848 |
| April 23, 2024 | 3.848 |
| April 22, 2024 | 3.775 |
| April 19, 2024 | 3.848 |
| April 18, 2024 | 3.739 |
| April 17, 2024 | 3.775 |
| April 16, 2024 | 3.920 |
| April 15, 2024 | 3.848 |
| April 12, 2024 | 4.138 |
| April 11, 2024 | 4.174 |
| April 10, 2024 | 4.102 |
| April 09, 2024 | 4.211 |
| April 08, 2024 | 4.211 |
| April 05, 2024 | 4.174 |
| April 04, 2024 | 4.174 |
| April 03, 2024 | 3.993 |
| April 02, 2024 | 3.884 |
| April 01, 2024 | 3.848 |
| March 28, 2024 | 3.848 |
| March 27, 2024 | 3.739 |
| March 26, 2024 | 3.666 |
| March 25, 2024 | 3.739 |
| March 22, 2024 | 3.630 |
| March 21, 2024 | 3.739 |
| Date | Value |
|---|---|
| March 20, 2024 | 3.666 |
| March 19, 2024 | 3.739 |
| March 18, 2024 | 3.775 |
| March 15, 2024 | 3.590 |
| March 14, 2024 | 3.702 |
| March 13, 2024 | 3.775 |
| March 12, 2024 | 3.848 |
| March 11, 2024 | 3.848 |
| March 08, 2024 | 3.811 |
| March 07, 2024 | 3.775 |
| March 06, 2024 | 3.725 |
| March 05, 2024 | 3.690 |
| March 04, 2024 | 3.295 |
| March 01, 2024 | 4.012 |
| February 29, 2024 | 4.084 |
| February 28, 2024 | 3.654 |
| February 27, 2024 | 3.725 |
| February 26, 2024 | 3.546 |
| February 23, 2024 | 3.535 |
| February 22, 2024 | 3.707 |
| February 21, 2024 | 3.654 |
| February 20, 2024 | 4.048 |
| February 16, 2024 | 4.155 |
| February 15, 2024 | 4.155 |
| February 14, 2024 | 4.119 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.747
Minimum
Jun 14 2022
39.13
Maximum
Dec 30 2019
5.391
Average
4.567
Median
Sep 30 2020
Price to Book Value Benchmarks
| Acasti Pharma Inc | 0.4256 |
| Aurinia Pharmaceuticals Inc | 1.863 |
| Edesa Biotech Inc | 2.425 |
| Lexaria Bioscience Corp | 4.328 |
| Xenon Pharmaceuticals Inc | 3.260 |
Price to Book Value Related Metrics
| Price | 1.08 |
| Earnings Yield | -28.20% |
| Market Cap | 81.45M |